Distinct roles for Blimp-1 in autoreactive CD4 T cells during priming and effector phase of autoimmune encephalomyelitis

[1]  R. Ko,et al.  Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation , 2018, Front. Immunol..

[2]  Yuhong Yang,et al.  IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity. , 2017, JCI insight.

[3]  Yuhong Yang,et al.  Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα , 2016, Journal of Neuroinflammation.

[4]  T. Speed,et al.  A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet , 2016, Nature Immunology.

[5]  T. Mcclanahan,et al.  Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells. , 2016, Immunity.

[6]  A. Tarakhovsky,et al.  Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation , 2016, Nature Immunology.

[7]  Yuhong Yang,et al.  Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis , 2015, Brain, Behavior, and Immunity.

[8]  S. Rutz,et al.  Role of Blimp-1 in programing Th effector cells into IL-10 producers , 2014, The Journal of experimental medicine.

[9]  B. Hemmer,et al.  IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1 , 2014, Nature Communications.

[10]  D. Chang,et al.  T cell-specific BLIMP-1 deficiency exacerbates experimental autoimmune encephalomyelitis in nonobese diabetic mice by increasing Th1 and Th17 cells. , 2014, Clinical immunology.

[11]  R. Ahmed,et al.  Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection , 2014, The Journal of experimental medicine.

[12]  T. Mcclanahan,et al.  Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23. , 2013, Cell reports.

[13]  S. Targan,et al.  B Lymphocyte–Induced Maturation Protein-1 Contributes to Intestinal Mucosa Homeostasis by Limiting the Number of IL-17–Producing CD4+ T Cells , 2012, The Journal of Immunology.

[14]  S. Holland,et al.  A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. , 2011, Immunity.

[15]  F. Barkhof,et al.  Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial , 2011, The Lancet.

[16]  Hailong Meng,et al.  Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection. , 2011, Immunity.

[17]  H. Oh,et al.  Autoreactive Memory CD4+ T Lymphocytes That Mediate Chronic Uveitis Reside in the Bone Marrow through STAT3-Dependent Mechanisms , 2011, The Journal of Immunology.

[18]  E. Wherry,et al.  T-bet represses expression of PD-1 and sustains virus-specific CD8 T cell responses during chronic infection , 2011, Nature Immunology.

[19]  T. Okazaki,et al.  PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice , 2011, The Journal of experimental medicine.

[20]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[21]  S. Crotty,et al.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation , 2010, Nature Immunology.

[22]  A. Bothwell,et al.  Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation , 2009, The Journal of experimental medicine.

[23]  A. Bothwell,et al.  Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation , 2009, The Journal of Experimental Medicine.

[24]  P. Calabresi,et al.  Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial , 2009, Annals of neurology.

[25]  S. Nutt,et al.  Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. , 2009, Immunity.

[26]  Burton E. Barnett,et al.  Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation , 2009, Science.

[27]  R. Nurieva,et al.  Bcl6 Mediates the Development of T Follicular Helper Cells , 2009, Science.

[28]  E. Meffre,et al.  Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. , 2009, Immunity.

[29]  Hyun-Dong Chang,et al.  Organization and maintenance of immunological memory by stroma niches , 2009, European journal of immunology.

[30]  Yuhong Yang,et al.  T-bet is essential for encephalitogenicity of both Th1 and Th17 cells , 2009, The Journal of experimental medicine.

[31]  Andreas Radbruch,et al.  Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. , 2009, Immunity.

[32]  T. Mcclanahan,et al.  The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.

[33]  K. Calame,et al.  Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival , 2008, The Journal of experimental medicine.

[34]  K. Calame,et al.  Blimp-1 Attenuates Th1 Differentiation by Repression of ifng, tbx21, and bcl6 Gene Expression , 2008, The Journal of Immunology.

[35]  K. Calame,et al.  Regulation and functions of Blimp-1 in T and B lymphocytes. , 2008, Annual review of immunology.

[36]  D. Arnold,et al.  Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial , 2008, Annals of neurology.

[37]  D. Arnold,et al.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. , 2008, The New England journal of medicine.

[38]  M. Leach,et al.  PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis , 2007, Journal of Neuroimmunology.

[39]  S. Nutt,et al.  Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance , 2006, Nature Immunology.

[40]  K. Calame,et al.  Transcriptional repressor Blimp-1 regulates T cell homeostasis and function , 2006, Nature Immunology.

[41]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[42]  K. Calame,et al.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow , 2005, The Journal of experimental medicine.

[43]  S. Pfeiffer,et al.  Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[45]  R. de Waal Malefyt,et al.  IL‐12 and IL‐23: master regulators of innate and adaptive immunity , 2004, Immunological reviews.

[46]  K. Calame,et al.  Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. , 2003, Immunity.

[47]  N. Ruddle,et al.  Rat and Human Myelin Oligodendrocyte Glycoproteins Induce Experimental Autoimmune Encephalomyelitis by Different Mechanisms in C57BL/6 Mice1 , 2003, Journal of Immunology.

[48]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[49]  Michael J. Ramsbottom,et al.  Critical role of antigen‐specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein , 2002, European journal of immunology.

[50]  H. McFarland,et al.  CD4+CD28- costimulation-independent T cells in multiple sclerosis. , 2001, The Journal of clinical investigation.

[51]  J. Burns,et al.  Isolation of myelin basic protein–specific T cells predominantly from the memory T‐cell compartment in multiple sclerosis , 1999, Annals of neurology.

[52]  C. June,et al.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. , 1998 .

[53]  D. E. Anderson,et al.  Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. , 1998, Journal of immunology.

[54]  J. Leonard,et al.  Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. , 1996, The American journal of pathology.

[55]  S. Hauser,et al.  The T‐cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements, and T‐cell receptor usage , 1993, Annals of neurology.

[56]  Jingwu Z. Zhang,et al.  Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity , 1992, Annals of neurology.

[57]  E. Sercarz,et al.  Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. , 1989, Cellular immunology.

[58]  C. Pettinelli,et al.  Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. , 1981, Journal of immunology.

[59]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.